Search results (14)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 November 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
17 November 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
PODCAST: Could vaccinations stop people from getting cancer?
12 November 2025
Professor Sarah Blagden discusses novel research approaches to cancer prevention on the Oxford Sparks podcast.
Michael Bryan wins international award at Europe’s largest cancer conference
24 October 2025
Michael - who is a CRUK Oxford Centre DPhil in Cancer Science student, working in the Nuffield Department of Medicine's Centre of Immuno-oncology - has been awarded the Best Poster Prize in CNS Tumours at the 2025 European Society for Medical Oncology (ESMO) Congress.
Professor Sarah Blagden to star in New Landmark Channel 4 Documentary Series 'Cancer Detectives: Finding the Cures'
16 October 2025
Channel 4 today announces 'Cancer Detectives: Finding the Cures', an observational documentary series that will explore the pioneering research that could transform the future of cancer detection, treatment and prevention.
AI supercomputer to help cancer vaccine research
27 August 2025
Researchers developing vaccines to treat cancer have been granted access to one of the UK's most powerful artificial intelligence (AI) supercomputers.
Dr Lennard Lee honoured at the national Cancer Vaccines Awards Ceremony
17 June 2025
Dr Lennard Lee, a leading cancer vaccine researcher from the Nuffield Department of Medicine, has been recognised at one of the UK’s most esteemed national oncology gatherings.
New vaccines that aim to prevent cancer: Starting the conversation
11 June 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
26 March 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
CRUK funding success to take LynchVax from an OCION Pump Prime award towards a clinical trial
16 September 2024
Fewer than 12 months ago the ‘Oxford Cancer Immuno-Oncology Network’ (OCION) awarded £20,000 Pump Prime funding to a team led by Associate Professor David Church, who has now grown this pot over 27-times in funding from CRUK!
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 September 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.